XML 102 R71.htm IDEA: XBRL DOCUMENT v3.25.4
COMMITMENTS AND CONTINGENCIES (Details)
$ in Millions
12 Months Ended
Dec. 31, 2025
USD ($)
Loss Contingencies [Line Items]  
Purchase obligation $ 1.6
Takeda Pharmaceuticals U.S.A., Inc.  
Loss Contingencies [Line Items]  
Licenses agreement, planned stockholder distribution from proceeds, percentage 25.00%